Monitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumShake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.InsulinGlargineTreatment&prevention ofbronchospasmin asthma andCOPD.AlbuterolSulfate Antidiabetics,rapid actinginsulinsObserve forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.PO/inhalationCaution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.Binds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.Do not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.Basaglar,Lantus,ToujouAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Monitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.Bronchodilators;adrenergicExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Administersubq within 5-10min beforemeal. Rotateinjection sites.Do not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.Administer oralmed with mealsto minimizegastric irritationInstruct ptsto contactHCPimmediatelyof SOB.NovologpancreaticInstruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.onset iswithin15minonset iswithin 3to 4hrchest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.antidiabetic,long-actinginsulinInsulinApartInform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.Stimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.SCExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Assess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.controlhyperglycemiain pts withT1/T2 DM.hypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.Monitor forhypokalemia asalbuterol maycause a decreasein serumpotassiumShake inhaler welland allow at least1min btw inhalations.Prime inhaler beforefirst use by releasing4 test sprays.InsulinGlargineTreatment&prevention ofbronchospasmin asthma andCOPD.AlbuterolSulfate Antidiabetics,rapid actinginsulinsObserve forparadoxicalbronchospasm(wheezing). NotifyHCP immediately ifcondition occurs.PO/inhalationCaution pt not toexceedrecommended dose,may cause adverseeffects or loss ofeffectiveness of med.Binds to beta 2 adrenergicreceptors in airway smoothmuscle by inhibitingphosphorylation of myosinand decrease intracellularcalcium leads to relaxationof smooth muscle airways.Do not mix insulinGlargine with otherinsulin. If giving witha short acting insulin,use separatesyringes and diffinjection sites.Basaglar,Lantus,ToujouAssess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.Monitor pulmonaryfunction testbefore initiatingtherapy andperiodically duringtherapy.Bronchodilators;adrenergicExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Administersubq within 5-10min beforemeal. Rotateinjection sites.Do not draw up dose into asyringe from the kiwi pens,syringe markings do notmatch up and could lead tomedication error. Prior towithdrawing dose, rotatevial btw palms to ensureuniform solution; do notshae.Administer oralmed with mealsto minimizegastric irritationInstruct ptsto contactHCPimmediatelyof SOB.NovologpancreaticInstruct pts on propertechniques for admin.Demonstratetechnique for mixinginsulins by drawingup insulin Aspart first.onset iswithin15minonset iswithin 3to 4hrchest pain,palpitations,nervousness,restlessness, tremor,paradoxicalbronchospasmw/excessive use.antidiabetic,long-actinginsulinInsulinApartInform pts of unusualbad taste. Advise ptsto rinse mouth aftereach inhalation tominimize dry mouth.Stimulate glucoseuptake in skeletalmuscle and fat,inhibit hepaticglucoseproduction.SCExplain to pts that thismed controlshyperglycemia butdoes not curediabetes, therapy islong term.Pts w/DM should carrya source of sugar.Assess lung sounds,pulse, BP beforeadmin and duringpeak of med. Noteamount, color, andcharacter of sputumproduced.Assess for symptomsof hypoglycemia.Monitor body weightperiodically. Assess ptsfor signs of allergic rxn.Monitor glucose q6hduring therapy. Monitorserum K+ in pts at riskfor hypokalemia.controlhyperglycemiain pts withT1/T2 DM.hypoglycemia,hypokalemia,erythema,lipodystrophy,pruritus,swelling.

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
  1. Monitor for hypokalemia as albuterol may cause a decrease in serum potassium
  2. Shake inhaler well and allow at least 1min btw inhalations. Prime inhaler before first use by releasing 4 test sprays.
  3. Insulin Glargine
  4. Treatment &prevention of bronchospasm in asthma and COPD.
  5. Albuterol Sulfate
  6. Antidiabetics, rapid acting insulins
  7. Observe for paradoxical bronchospasm (wheezing). Notify HCP immediately if condition occurs.
  8. PO/inhalation
  9. Caution pt not to exceed recommended dose, may cause adverse effects or loss of effectiveness of med.
  10. Binds to beta 2 adrenergic receptors in airway smooth muscle by inhibiting phosphorylation of myosin and decrease intracellular calcium leads to relaxation of smooth muscle airways.
  11. Do not mix insulin Glargine with other insulin. If giving with a short acting insulin, use separate syringes and diff injection sites.
  12. Basaglar, Lantus, Toujou
  13. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  14. Monitor pulmonary function test before initiating therapy and periodically during therapy.
  15. Bronchodilators; adrenergic
  16. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  17. Administer subq within 5-10min before meal. Rotate injection sites.
  18. Do not draw up dose into a syringe from the kiwi pens, syringe markings do not match up and could lead to medication error. Prior to withdrawing dose, rotate vial btw palms to ensure uniform solution; do not shae.
  19. Administer oral med with meals to minimize gastric irritation
  20. Instruct pts to contact HCP immediately of SOB.
  21. Novolog
  22. pancreatic
  23. Instruct pts on proper techniques for admin. Demonstrate technique for mixing insulins by drawing up insulin Aspart first.
  24. onset is within 15min
  25. onset is within 3 to 4hr
  26. chest pain, palpitations, nervousness, restlessness, tremor, paradoxical bronchospasm w/excessive use.
  27. antidiabetic, long-acting insulin
  28. Insulin Apart
  29. Inform pts of unusual bad taste. Advise pts to rinse mouth after each inhalation to minimize dry mouth.
  30. Stimulate glucose uptake in skeletal muscle and fat, inhibit hepatic glucose production.
  31. SC
  32. Explain to pts that this med controls hyperglycemia but does not cure diabetes, therapy is long term. Pts w/DM should carry a source of sugar.
  33. Assess lung sounds, pulse, BP before admin and during peak of med. Note amount, color, and character of sputum produced.
  34. Assess for symptoms of hypoglycemia. Monitor body weight periodically. Assess pts for signs of allergic rxn. Monitor glucose q6h during therapy. Monitor serum K+ in pts at risk for hypokalemia.
  35. control hyperglycemia in pts with T1/T2 DM.
  36. hypoglycemia, hypokalemia, erythema, lipodystrophy, pruritus, swelling.